Published on: 27 June 2018 Roche’s Actemra approved in Switzerland for patients with giant cell arteritis more
Published on: 3 April 2018 Roche’s Alecensa (alectinib) approved as a first-line treatment for people with a specific type of lung cancer in Switzerland more
Subscribe to Roche Media Releases for Switzerland Get the latest news and updates to your inbox. more
